GSK Plc (GLAXF)
24.56
+0.56
(+2.34%)
USD |
OTCM |
Sep 15, 16:00
GSK Market Cap : 99.36B for Sept. 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 15, 2026 | 99.36B |
| September 14, 2026 | 97.09B |
| September 11, 2026 | 97.09B |
| September 10, 2026 | 97.09B |
| September 09, 2026 | 95.11B |
| September 08, 2026 | 101.96B |
| September 04, 2026 | 101.96B |
| September 03, 2026 | 103.16B |
| September 02, 2026 | 101.05B |
| September 01, 2026 | 101.05B |
| August 31, 2026 | 101.79B |
| August 28, 2026 | 103.48B |
| August 27, 2026 | 102.53B |
| August 26, 2026 | 99.52B |
| August 25, 2026 | 99.52B |
| August 24, 2026 | 103.42B |
| August 21, 2026 | 103.16B |
| August 20, 2026 | 102.55B |
| August 19, 2026 | 102.55B |
| August 18, 2026 | 102.55B |
| August 17, 2026 | 102.55B |
| August 14, 2026 | 102.81B |
| August 13, 2026 | 102.81B |
| August 12, 2026 | 101.89B |
| August 11, 2026 | 104.61B |
| Date | Value |
|---|---|
| August 10, 2026 | 104.61B |
| August 07, 2026 | 104.61B |
| August 06, 2026 | 104.61B |
| August 05, 2026 | 104.61B |
| August 04, 2026 | 99.92B |
| August 03, 2026 | 104.03B |
| July 31, 2026 | 100.93B |
| July 30, 2026 | 101.22B |
| July 29, 2026 | 105.48B |
| July 28, 2026 | 107.45B |
| July 27, 2026 | 107.20B |
| July 24, 2026 | 102.40B |
| July 23, 2026 | 102.40B |
| July 22, 2026 | 104.21B |
| July 21, 2026 | 104.21B |
| July 20, 2026 | 104.21B |
| July 17, 2026 | 104.21B |
| July 16, 2026 | 103.16B |
| July 15, 2026 | 103.82B |
| July 14, 2026 | 106.35B |
| July 13, 2026 | 106.35B |
| July 10, 2026 | 106.35B |
| July 09, 2026 | 106.35B |
| July 08, 2026 | 106.35B |
| July 07, 2026 | 109.23B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AstraZeneca PLC | 502.00B |
| Hikma Pharmaceuticals Plc | 4.374B |
| Allergy Therapeutics Plc | 921.22M |
| Shield Therapeutics Plc | 91.58M |
| Futura Medical Plc | 1.512M |
Market Cap Related Metrics
| PE Ratio | 15.48 |
| PS Ratio | 2.250 |
| PEG Ratio | 0.3228 |
| Price to Book Value | 4.243 |
| Price to Free Cash Flow | 15.26 |
| Price | 24.56 |
| Earnings Yield | 6.46% |
| PEGY Ratio | 0.2996 |
| Operating PE Ratio | 8.998 |
| Normalized PE Ratio | 10.65 |